메뉴 건너뛰기




Volumn 12, Issue 4, 2012, Pages 406-411

Omalizumab in chronic urticaria

Author keywords

anti immunoglobulin (Ig) E; mast cell; physical urticaria; spontaneous urticaria; Xolair

Indexed keywords

CYCLOSPORIN A; DAPSONE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OMALIZUMAB; PLACEBO; THYROID PEROXIDASE ANTIBODY;

EID: 84864235267     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e328355365a     Document Type: Review
Times cited : (62)

References (48)
  • 2
    • 65549130606 scopus 로고    scopus 로고
    • The German version of the Chronic Urticaria Quality-of-Life Questionnaire: Factor analysis, validation, and initial clinical findings
    • Mlynek A, Magerl M, Hanna M, et al. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009; 64:927-936.
    • (2009) Allergy , vol.64 , pp. 927-936
    • Mlynek, A.1    Magerl, M.2    Hanna, M.3
  • 3
    • 70349210289 scopus 로고    scopus 로고
    • EAACI/GA(2)LEN/EDF/WAO guideline: Management of urticaria
    • Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64:1427-1443.
    • (2009) Allergy , vol.64 , pp. 1427-1443
    • Zuberbier, T.1    Asero, R.2    Bindslev-Jensen, C.3
  • 4
    • 70349214906 scopus 로고    scopus 로고
    • EAACI/GA(2)LEN/EDF/WAO guideline: Definition, classification and diagnosis of urticaria
    • Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64:1417-1426.
    • (2009) Allergy , vol.64 , pp. 1417-1426
    • Zuberbier, T.1    Asero, R.2    Bindslev-Jensen, C.3
  • 5
    • 84864202434 scopus 로고    scopus 로고
    • Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common moulds
    • Staubach P, Vonend A, Burow G, et al.. Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common moulds. Mycoses 2008.
    • (2008) Mycoses
    • Staubach, P.1    Vonend, A.2    Burow, G.3
  • 6
    • 0017367289 scopus 로고
    • Solar urticaria. Photoallergen in a patient's serum
    • DOI 10.1001/archderm.113.2.157
    • Horio T, Minami K. Solar uticaria. Photoallergen in a patients serum. Arch Dermatol 1977; 113:157-160. (Pubitemid 8033151)
    • (1977) Archives of Dermatology , vol.113 , Issue.2 , pp. 157-160
    • Horio, T.1    Minami, K.2
  • 7
    • 0024240589 scopus 로고
    • Cholinergic urticaria, passive transfer experiments from human to monkey
    • Murphy GM, Greaves MW, Zollman PE, Winkelmann RK. Cholinergic urticaria, passive transfer experiments from human to monkey. Dermatologica 1988; 177:338-340. (Pubitemid 19044327)
    • (1988) Dermatologica , vol.177 , Issue.6 , pp. 338-340
    • Murphy, G.M.1    Greaves, M.W.2    Zollman, P.E.3    Winkelmann, R.K.4
  • 8
    • 0023268805 scopus 로고
    • Symptomatic dermographism (factitious urticaria) - passive transfer experiments from human to monkey
    • DOI 10.1111/j.1365-2133.1987.tb04898.x
    • Murphy GM, Zollman PE, Greaves MW, Winkelmann RK. Symptomatic dermographism (factitious urticaria): passive transfer experiments from human to monkey. Br J Dermatol 1987; 116:801-804. (Pubitemid 17075399)
    • (1987) British Journal of Dermatology , vol.116 , Issue.6 , pp. 801-804
    • Murphy, G.M.1    Zollman, P.E.2    Greaves, M.W.3    Winkelmann, R.K.4
  • 9
    • 79954462805 scopus 로고    scopus 로고
    • IgE mediated autoallergy against thyroid peroxidase: A novel pathomechanism of chronic spontaneous urticaria?
    • Altrichter S, Peter HJ, Pisarevskaja D, et al. IgE mediated autoallergy against thyroid peroxidase: a novel pathomechanism of chronic spontaneous urticaria? PLoS One 2011; 6:e14794.
    • (2011) PLoS One , vol.6
    • Altrichter, S.1    Peter, H.J.2    Pisarevskaja, D.3
  • 10
    • 80052299857 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, doseranging study of single-dose omalizumab in patients with H1-antihistaminerefractory chronic idiopathic urticaria
    • Saini S, Rosen KE, Hsieh HJ, et al. A randomized, placebo-controlled, doseranging study of single-dose omalizumab in patients with H1-antihistaminerefractory chronic idiopathic urticaria. J Allergy Clin Immunol 2011; 128:567-573.
    • (2011) J Allergy Clin Immunol , vol.128 , pp. 567-573
    • Saini, S.1    Rosen, K.E.2    Hsieh, H.J.3
  • 11
    • 79959855552 scopus 로고    scopus 로고
    • Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
    • e205
    • Maurer M, Altrichter S, Bieber T, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol 2011; 128:202e205-209e205.
    • (2011) J Allergy Clin Immunol , vol.128 , Issue.202
    • Maurer, M.1    Altrichter, S.2    Bieber, T.3
  • 12
    • 84859799340 scopus 로고    scopus 로고
    • Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey
    • Büyüköztürk S, Gelincik A, Demirturk M, et al. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey. J Dermatol 2012; 39:439-442.
    • (2012) J Dermatol , vol.39 , pp. 439-442
    • Büyüköztürk, S.1    Gelincik, A.2    Demirturk, M.3
  • 13
    • 80052872083 scopus 로고    scopus 로고
    • Omalizumab in treatment-resistant chronic spontaneous urticaria
    • Godse KV. Omalizumab in treatment-resistant chronic spontaneous urticaria. Indian J Dermatol 2011; 56:444.
    • (2011) Indian J Dermatol , vol.56 , pp. 444
    • Godse, K.V.1
  • 14
    • 79955575746 scopus 로고    scopus 로고
    • Omalizumab is effective in nonautoimmune urticaria
    • Ferrer M, Gamboa P, Sanz ML, et al. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol 2011; 127:1300-1302.
    • (2011) J Allergy Clin Immunol , vol.127 , pp. 1300-1302
    • Ferrer, M.1    Gamboa, P.2    Sanz, M.L.3
  • 15
    • 78651096597 scopus 로고    scopus 로고
    • Omalizumab: An effective and safe treatment of therapy-resistant chronic spontaneous urticaria
    • Groffik A, Mitzel-Kaoukhov H, Magerl M, et al. Omalizumab: an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy 2011; 66:303-305.
    • (2011) Allergy , vol.66 , pp. 303-305
    • Groffik, A.1    Mitzel-Kaoukhov, H.2    Magerl, M.3
  • 16
    • 78649383197 scopus 로고    scopus 로고
    • Omalizumab therapy in three patients with chronic autoimmune urticaria
    • Al-Ahmad M. Omalizumab therapy in three patients with chronic autoimmune urticaria. Ann Saudi Med 2010; 30:478-481.
    • (2010) Ann Saudi Med , vol.30 , pp. 478-481
    • Al-Ahmad, M.1
  • 17
    • 77956394970 scopus 로고    scopus 로고
    • Effective treatment of therapyresistant chronic spontaneous urticaria with omalizumab
    • Magerl M, Staubach P, Altrichter S, et al. Effective treatment of therapyresistant chronic spontaneous urticaria with omalizumab. J Allergy Clin Immunol 2010; 126:665-666.
    • (2010) J Allergy Clin Immunol , vol.126 , pp. 665-666
    • Magerl, M.1    Staubach, P.2    Altrichter, S.3
  • 18
    • 50649084564 scopus 로고    scopus 로고
    • Treatment of chronic autoimmune urticaria with omalizumab
    • Kaplan AP, Joseph K, Maykut RJ, et al. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008; 122:569-573.
    • (2008) J Allergy Clin Immunol , vol.122 , pp. 569-573
    • Kaplan, A.P.1    Joseph, K.2    Maykut, R.J.3
  • 19
    • 34547944181 scopus 로고    scopus 로고
    • Effect of omalizumab on patients with chronic urticaria
    • Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 2007; 99:190-193. (Pubitemid 47264781)
    • (2007) Annals of Allergy, Asthma and Immunology , vol.99 , Issue.2 , pp. 190-193
    • Spector, S.L.1    Tan, R.A.2
  • 20
  • 21
    • 79960694270 scopus 로고    scopus 로고
    • T cell activity in successful treatment of chronic urticaria with omalizumab
    • Sánchez-Machin I, Iglesias-Souto J, Franco A, et al. T cell activity in successful treatment of chronic urticaria with omalizumab. Clin Mol Allergy 2011; 9:11.
    • (2011) Clin Mol Allergy , vol.9 , pp. 11
    • Sánchez-Machin, I.1    Iglesias-Souto, J.2    Franco, A.3
  • 22
    • 78651483333 scopus 로고    scopus 로고
    • Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab
    • Saavedra MC, Sur S. Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab. Clin Mol Allergy 2011; 9:2.
    • (2011) Clin Mol Allergy , vol.9 , pp. 2
    • Saavedra, M.C.1    Sur, S.2
  • 23
    • 79952276285 scopus 로고    scopus 로고
    • Omalizumab for therapy-resistant chronic urticaria with angioedema
    • Korkmaz H, Eigelshoven S, Homey B. Omalizumab for therapy-resistant chronic urticaria with angioedema. Hautarzt 2010; 61:828-831.
    • (2010) Hautarzt , vol.61 , pp. 828-831
    • Korkmaz, H.1    Eigelshoven, S.2    Homey, B.3
  • 24
    • 77954362538 scopus 로고    scopus 로고
    • Immunological effects of omalizumab in chronic urticaria: A case report
    • Iemoli E, Piconi S, Fusi A, et al. Immunological effects of omalizumab in chronic urticaria: a case report. J Investig Allergol Clin Immunol 2010; 20:252-254.
    • (2010) J Investig Allergol Clin Immunol , vol.20 , pp. 252-254
    • Iemoli, E.1    Piconi, S.2    Fusi, A.3
  • 25
    • 77954941791 scopus 로고    scopus 로고
    • Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab
    • Vestergaard C, Deleuran M. Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab. Acta Derm Venereol 2010; 90:443-444.
    • (2010) Acta Derm Venereol , vol.90 , pp. 443-444
    • Vestergaard, C.1    Deleuran, M.2
  • 26
    • 76749153779 scopus 로고    scopus 로고
    • Maintenance of remission with lowdose omalizumab in long-lasting, refractory chronic urticaria
    • Romano C, Sellitto A, De Fanis U, et al. Maintenance of remission with lowdose omalizumab in long-lasting, refractory chronic urticaria. Ann Allergy Asthma Immunol 2010; 104:95-97.
    • (2010) Ann Allergy Asthma Immunol , vol.104 , pp. 95-97
    • Romano, C.1    Sellitto, A.2    De Fanis, U.3
  • 28
    • 0016812740 scopus 로고
    • In vivo studies of mediator release in cold urticaria and cholinergic urticaria
    • Kaplan AP, Gray L, Shaff RE, et al. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol 1975; 55:394-402.
    • (1975) J Allergy Clin Immunol , vol.55 , pp. 394-402
    • Kaplan, A.P.1    Gray, L.2    Shaff, R.E.3
  • 29
    • 0015583068 scopus 로고
    • Dermographia mediated by immunoglobulin e
    • Newcomb RW, Nelson H. Dermographia mediated by immunoglobulin E. Am J Med 1973; 54:174-180.
    • (1973) Am J Med , vol.54 , pp. 174-180
    • Newcomb, R.W.1    Nelson, H.2
  • 31
    • 33646947344 scopus 로고    scopus 로고
    • Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE
    • DOI 10.1016/j.jaci.2006.04.003, PII S0091674906008529
    • Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006; 117:1415-1418. (Pubitemid 43795744)
    • (2006) Journal of Allergy and Clinical Immunology , vol.117 , Issue.6 , pp. 1415-1418
    • Boyce, J.A.1
  • 32
    • 77956078962 scopus 로고    scopus 로고
    • Antiimmunoglobulin e treatment of patients with recalcitrant physical urticaria
    • Metz M, Altrichter S, Ardelean E, et al. Antiimmunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol 2011; 154:177-180.
    • (2011) Int Arch Allergy Immunol , vol.154 , pp. 177-180
    • Metz, M.1    Altrichter, S.2    Ardelean, E.3
  • 33
    • 81355154609 scopus 로고    scopus 로고
    • Failure of omalizumab (Xolair(R)) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light
    • Duchini G, Baumler W, Bircher AJ, Scherer K. Failure of omalizumab (Xolair(R)) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light. Photodermatol Photoimmunol Photomed 2011; 27:336-337.
    • (2011) Photodermatol Photoimmunol Photomed , vol.27 , pp. 336-337
    • Duchini, G.1    Baumler, W.2    Bircher, A.J.3    Scherer, K.4
  • 34
    • 78649260196 scopus 로고    scopus 로고
    • Antihistamine-resistant urticaria factitia successfully treated with antiimmunoglobulin e therapy
    • Krause K, Ardelean E, Kessler B, et al. Antihistamine-resistant urticaria factitia successfully treated with antiimmunoglobulin E therapy. Allergy 2010; 65:1494-1495.
    • (2010) Allergy , vol.65 , pp. 1494-1495
    • Krause, K.1    Ardelean, E.2    Kessler, B.3
  • 36
    • 77953111313 scopus 로고    scopus 로고
    • Effective treatment of refractory severe heat urticaria with omalizumab
    • Bullerkotte U, Wieczorek D, Kapp A, Wedi B. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy 2010; 65:931-932.
    • (2010) Allergy , vol.65 , pp. 931-932
    • Bullerkotte, U.1    Wieczorek, D.2    Kapp, A.3    Wedi, B.4
  • 37
    • 77951241500 scopus 로고    scopus 로고
    • Failure of omalizumab in cholinergic urticaria
    • Sabroe RA. Failure of omalizumab in cholinergic urticaria. Clin Exp Dermatol 2010; 35:e127-e129.
    • (2010) Clin Exp Dermatol , vol.35
    • Sabroe, R.A.1
  • 38
    • 72049102902 scopus 로고    scopus 로고
    • Efficacy of omalizumab in delayed pressure urticaria: A case report
    • Bindslev-Jensen C, Skov PS. Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy 2010; 65:138-139.
    • (2010) Allergy , vol.65 , pp. 138-139
    • Bindslev-Jensen, C.1    Skov, P.S.2
  • 39
    • 53749100152 scopus 로고    scopus 로고
    • Successful treatment of solar urticaria with antiimmunoglobulin e therapy
    • Güzelbey O, Ardelean E, Magerl M, et al. Successful treatment of solar urticaria with antiimmunoglobulin E therapy. Allergy 2008; 63:1563-1565.
    • (2008) Allergy , vol.63 , pp. 1563-1565
    • Güzelbey, O.1    Ardelean, E.2    Magerl, M.3
  • 40
    • 37749011236 scopus 로고    scopus 로고
    • Successful treatment of cholinergic urticaria with antiimmunoglobulin e therapy
    • Metz M, Bergmann P, Zuberbier T, Maurer M. Successful treatment of cholinergic urticaria with antiimmunoglobulin E therapy. Allergy 2008; 63:247-249.
    • (2008) Allergy , vol.63 , pp. 247-249
    • Metz, M.1    Bergmann, P.2    Zuberbier, T.3    Maurer, M.4
  • 43
    • 67649366101 scopus 로고    scopus 로고
    • The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
    • Holgate S, Buhl R, Bousquet J, et al. The use of omalizumab in the treatment of severe allergic asthma: a clinical experience update. Respir Med 2009; 103:1098-1113.
    • (2009) Respir Med , vol.103 , pp. 1098-1113
    • Holgate, S.1    Buhl, R.2    Bousquet, J.3
  • 44
    • 49549122199 scopus 로고    scopus 로고
    • Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis
    • Altrichter S, Kriehuber E, Moser J, et al. Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J Invest Dermatol 2008; 128:2232-2239.
    • (2008) J Invest Dermatol , vol.128 , pp. 2232-2239
    • Altrichter, S.1    Kriehuber, E.2    Moser, J.3
  • 45
    • 80051529993 scopus 로고    scopus 로고
    • IgE and IgG(4) autoantibodies against DFS70/LEDGF in atopic dermatitis
    • Watanabe K, Muro Y, Sugiura K, Tomita Y. IgE and IgG(4) autoantibodies against DFS70/LEDGF in atopic dermatitis. Autoimmunity 2011; 44:511-519.
    • (2011) Autoimmunity , vol.44 , pp. 511-519
    • Watanabe, K.1    Muro, Y.2    Sugiura, K.3    Tomita, Y.4
  • 46
    • 79960383879 scopus 로고    scopus 로고
    • FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid
    • Messingham KN, Srikantha R, DeGueme AM, Fairley JA. FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid. J Immunol 2011; 187:553-560.
    • (2011) J Immunol , vol.187 , pp. 553-560
    • Messingham, K.N.1    Srikantha, R.2    Degueme, A.M.3    Fairley, J.A.4
  • 48
    • 61549086236 scopus 로고    scopus 로고
    • Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab
    • Fairley JA, Baum CL, Brandt DS, Messingham KA. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. J Allergy Clin Immunol 2009; 123:704-705.
    • (2009) J Allergy Clin Immunol , vol.123 , pp. 704-705
    • Fairley, J.A.1    Baum, C.L.2    Brandt, D.S.3    Messingham, K.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.